D-0300-2026 Class III Ongoing
FDA drug recall D-0300-2026 was initiated by NOVADOZ PHARMACEUTICALS LLC on Dec 15, 2025 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications The recall status is ongoing.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 4, 2026
- Initiation Date
- Dec 15, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
Glycopyrrolate Oral Solution, 1 mg/5 mL, 16 oz. (473 mL), Rx only, Manufactured by: MSN Pharmaceuticals Inc., Piscataway, NJ 08854, Distributed by: Novadoz Pharmaceuticals LLC, Piscataway, NJ 08854, NDC 72205-070-72
Reason for recall
Failed Impurities/Degradation Specifications
Distribution pattern
US Nationwide.
Code information
Lot # CB2505159A, CB2505160A, Exp Date: 04/2027; Lot # CB2505161A, Exp Date: 05/2027
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0300-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026